These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6455793)

  • 1. Prolonged allograft survival of strong pretransplant immune responders treated with ATG.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplant Proc; 1981 Mar; 13(1 Pt 1):332-5. PubMed ID: 6455793
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant T cell levels and renal allograft survival.
    Uittenbogaart CH; Robinson BJ; Malekzadeh MH; Pennisi AJ; Ettenger RB; Fine RN
    Proc Eur Dial Transplant Assoc; 1979; 16():449-53. PubMed ID: 398517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithymocyte globulin therapy.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplantation; 1980 Dec; 30(6):450-4. PubMed ID: 7008294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of cadaveric allograft survival based on pretransplant nonspecific immunocompetence.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplant Proc; 1981 Sep; 13(3):1533-5. PubMed ID: 7029808
    [No Abstract]   [Full Text] [Related]  

  • 6. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of ALG and ATG in clinical renal transplantation--recent European experience.
    Groth CG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):460-1. PubMed ID: 7022873
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic correlates of human renal allograft survival.
    Etheredge EE; Sicard GA; Anderson CB
    Transplant Proc; 1979 Mar; 11(1):354-9. PubMed ID: 377655
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of blood transfusion on immune responses and their relationship to renal allograft survival.
    Goeken NE; Flanigan MJ; Thompson JS; Corry RJ; Nghiem DD; Rhoades JL; Evans GA; Melton ZJ
    Transplant Proc; 1982 Jun; 14(2):338-40. PubMed ID: 6214062
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients.
    Fuller TC; Cosimi AB; Russell PS
    Transplant Proc; 1978 Jun; 10(2):463-6. PubMed ID: 354136
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of azathioprine on kidney allograft tolerance induced by rabbit ATG and donor bone marrow in primates.
    Thomas J; Carver M; Cunningham P; Gonder J; McGaley C; Sash C; Thomas F
    Transplant Proc; 1987 Feb; 19(1 Pt 1):472-5. PubMed ID: 3547827
    [No Abstract]   [Full Text] [Related]  

  • 13. Semi-specific immunosuppression in canine kidney allograft with I131 labelled ATG.
    Corman J; Smeesters C; Giroux L; St-Louis G; Leveille M; Lavigne CM; Lamoureux J; Jean G; Daloze P
    Transplant Proc; 1982 Dec; 14(4):656-8. PubMed ID: 6188256
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
    Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
    Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.
    Thomas JM; Carver FM; Foil MB; Hall WR; Adams C; Fahrenbruch GB; Thomas FT
    Transplantation; 1983 Jul; 36(1):104-6. PubMed ID: 6346606
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette).
    Byfield PE; Barth CL; Brodie JA; Cosimi AB; Dienst SG; Elberg AJ; Elfring GL; Hardy MA; Hayashi H; Kountz SL; Lamborn KR; Loughman BE; Sakai A; Satoh PS; Zielinski CM; Wechter WJ
    Transplant Proc; 1978 Sep; 10(3):627-31. PubMed ID: 362648
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ATG therapy.
    Grosse-Wilde H; Jakubowski HD; Eigler FW; Kuwert EK
    Proc Eur Dial Transplant Assoc; 1981; 18():481-5. PubMed ID: 7036170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL
    Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival.
    Thomas JM; Carver FM; Cunningham PR; Gross U; Verbanac KM; Rebellato LM; Riley R; Thomas FT
    Transplant Proc; 1993 Feb; 25(1 Pt 1):342-3. PubMed ID: 8438326
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretransplant assays of alloimmunity in predicting renal graft outcome.
    Gailiunas P; Person A; Suthanthiran M; Carpenter CB; Garovoy MR
    Proc Clin Dial Transplant Forum; 1977; 7():1-3. PubMed ID: 356029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.